170 related articles for article (PubMed ID: 19449159)
1. The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention: the case of general colorectal cancer screening in the German population.
Tscheulin DK; Drevs F
Eur J Health Econ; 2010 Apr; 11(2):141-50. PubMed ID: 19449159
[TBL] [Abstract][Full Text] [Related]
2. Estimating health benefits and cost-savings for achieving the Healthy People 2020 objective of reducing invasive colorectal cancer.
Hung MC; Ekwueme DU; White A; Rim SH; King JB; Wang JD; Chang SH
Prev Med; 2018 Jan; 106():38-44. PubMed ID: 28964854
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness and budget impact analyses of a colorectal cancer screening programme in a high adenoma prevalence scenario using MISCAN-Colon microsimulation model.
Arrospide A; Idigoras I; Mar J; de Koning H; van der Meulen M; Soto-Gordoa M; Martinez-Llorente JM; Portillo I; Arana-Arri E; Ibarrondo O; Lansdorp-Vogelaar I
BMC Cancer; 2018 Apr; 18(1):464. PubMed ID: 29695234
[TBL] [Abstract][Full Text] [Related]
4. Family history assessment to detect increased risk for colorectal cancer: conceptual considerations and a preliminary economic analysis.
Ramsey SD; Burke W; Pinsky L; Clarke L; Newcomb P; Khoury MJ
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2494-500. PubMed ID: 16284369
[TBL] [Abstract][Full Text] [Related]
5. Financial protection and equity in the healthcare financing system in Iran: a cross-sectional study among slum dwellers with type 2 diabetes.
Ghammari F; Heidari K; Jalilian H
BMJ Open; 2024 May; 14(5):e081989. PubMed ID: 38702082
[TBL] [Abstract][Full Text] [Related]
6. Incorporating future unrelated medical costs in cost-effectiveness analysis in China.
Jiang S; Wang Y; Zhou J; Jiang Y; Liu GG; Wu J
BMJ Glob Health; 2021 Oct; 6(10):. PubMed ID: 34702751
[TBL] [Abstract][Full Text] [Related]
7. Lifetime medical costs of obesity: prevention no cure for increasing health expenditure.
van Baal PH; Polder JJ; de Wit GA; Hoogenveen RT; Feenstra TL; Boshuizen HC; Engelfriet PM; Brouwer WB
PLoS Med; 2008 Feb; 5(2):e29. PubMed ID: 18254654
[TBL] [Abstract][Full Text] [Related]
8. Early retirement and the influence on healthcare budgets and insurance premiums in a diabetes population.
Walzer S
Vasc Health Risk Manag; 2007; 3(3):331-41. PubMed ID: 17703641
[TBL] [Abstract][Full Text] [Related]
9. Costs of cancer care for use in economic evaluation: a UK analysis of patient-level routine health system data.
Hall PS; Hamilton P; Hulme CT; Meads DM; Jones H; Newsham A; Marti J; Smith AF; Mason H; Velikova G; Ashley L; Wright P
Br J Cancer; 2015 Mar; 112(5):948-56. PubMed ID: 25602964
[TBL] [Abstract][Full Text] [Related]
10. Cost savings in the Swiss healthcare system resulting from professional periodontal care.
Ramseier CA; Manamel R; Budmiger R; Cionca N; Sahrmann P; Schmidlin PR; Martig L
Swiss Dent J; 2022 Nov; 132(11):764-779. PubMed ID: 36047013
[TBL] [Abstract][Full Text] [Related]
11. Direct Medical Spending on Young and Average-Age Onset Colorectal Cancer before and after Diagnosis: a Population-Based Costing Study.
Garg R; Sayre EC; Pataky R; McTaggart-Cowan H; Peacock S; Loree JM; McKenzie M; Brown CJ; Yeung SST; De Vera MA
Cancer Epidemiol Biomarkers Prev; 2024 Jan; 33(1):72-79. PubMed ID: 37878338
[TBL] [Abstract][Full Text] [Related]
12. Cost analysis of youth clinic network in Estonia.
Kempers J
Reprod Health; 2015 May; 12():37. PubMed ID: 25928107
[TBL] [Abstract][Full Text] [Related]
13. The Use of Precision Epigenetic Methods for the Diagnosis and Care of Stable Coronary Heart Disease Reduces Healthcare Costs.
Frisvold D; Dogan M; Dogan T; Abdullahi K; Koep T; Philibert R
Adv Ther; 2024 Jun; 41(6):2367-2380. PubMed ID: 38662186
[TBL] [Abstract][Full Text] [Related]
14. Health economic benefits through the use of diagnostic support systems and expert knowledge.
Willmen T; Völkel L; Ronicke S; Hirsch MC; Kaufeld J; Rychlik RP; Wagner AD
BMC Health Serv Res; 2021 Sep; 21(1):947. PubMed ID: 34503507
[TBL] [Abstract][Full Text] [Related]
15. Assessing the future medical cost burden for the European health systems under alternative exposure-to-risks scenarios.
Goryakin Y; Thiébaut SP; Cortaredona S; Lerouge MA; Cecchini M; Feigl AB; Ventelou B
PLoS One; 2020; 15(9):e0238565. PubMed ID: 32915826
[TBL] [Abstract][Full Text] [Related]
16. [Swiss healthcare system: a bulimic machine].
Grandchamp C; Monod S
Rev Med Suisse; 2024 Mar; 20(867):666-671. PubMed ID: 38563542
[TBL] [Abstract][Full Text] [Related]
17. Budgetary targets as cost-containment measure in the Swiss healthcare system? Lessons from abroad.
Braendle T; Colombier C
Health Policy; 2020 Jun; 124(6):605-614. PubMed ID: 32473748
[TBL] [Abstract][Full Text] [Related]
18. What are the Changes in 2023 for Access to Advanced Therapy Medicinal Products (ATMPs) in France?
Bartos B
Eur J Health Law; 2024 Jan; 31(2):187-208. PubMed ID: 38280386
[TBL] [Abstract][Full Text] [Related]
19. Cost-benefit estimates of an elderly exercise program on Kaua'i.
Sugihara N; Watanabe M; Tomioka M; Braun KL; Pang L
Hawaii Med J; 2011 Jun; 70(6):116-20. PubMed ID: 22162608
[TBL] [Abstract][Full Text] [Related]
20. Including environmental and social sustainability in the planning process of healthcare services: A case study of cancer screening programs in an inner area in Italy.
Benedetto V; Ferrè F; Nuti S
Health Policy; 2024 Jun; 144():105074. PubMed ID: 38652936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
